ArticleJournal of hepatocellular carcinoma2025
Preoperative Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma Using Machine Learning-Based Ultrasomics.
Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Macrotrabecular-massive subtype in hepatocellular carcinoma based on contrast-enhanced CT: deep learning outperforms machine learning.Insights into imaging · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Macrotrabecular-massive hepatocellular carcinoma (MTM-HCC) is a special pathological subtype of HCC, which is related to invasiveness and poor prognosis. We aimed to construct an ultrasomics model for preoperative noninvasive prediction of MTM-HCC. Patients and Methods: Patients with pathologically confirmed HCC who underwent liver surgery between January 2021 and December 2023 were retrospectively enrolled. 211 eligible patients (169 males and 42 females) were divided 7:3 into the training set (n=147) and test set (n=64) by random stratified sampling. Ultrasomics models were constructed based on the ultrasound image features of the training set using five different ML algorithms, including random forest (RF), eXtreme gradient boosting (XGBoost), support vector machine (SVM), decision tree (DT), and logistic regression (LR). Additionally, a model based on clinical features and a combined model based on clinical and ultrasomics features were constructed to predict MTM-HCC. The performance of the models in the preoperative prediction of MTM-HCC was evaluated on the test set using area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and accuracy. Results: The ultrasomics models and the combined models of the five algorithms were effective in predicting MTM-HCC, and the combined models have improved AUC after adding clinical features compared with the ultrasomics model in the test set. The model constructed based on the RF algorithm in the test set has a high accuracy rate and specificity, and the overall performance of the models is better than that of the other four algorithm models, the AUC, accuracy, specificity, and sensitivity of its combined model and ultrasomics model are significantly higher than the clinical model. Conclusion: ML-based ultrasomics model is an effective tool for predicting MTM-HCC before surgery. Integrating clinical and ultrasound image features enhances predictive performance, offering a novel approach for non-invasive preoperative diagnosis of MTM-HCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.